1. A joint investigation into cosmetic surgery chains has uncovered disfiguring injuries and deaths, prompting an urgent warning from plastic surgeons.
2. High-pressure sales tactics and misleading ads from private equity-backed clinics have created a “buyer beware” market for high-risk elective procedures.
A high-stakes joint investigation by KFF Health News and NBC News, titled “The Body Shops,” has sent shockwaves through the elective surgery market. Released in mid-March 2026, the series documented numerous cases of disfiguring injuries and deaths linked to high-volume cosmetic surgery chains. These clinics, some owned by private equity groups, are accused of using high-pressure sales tactics that downplay the inherent risks of major operations. In response, the American Society of Plastic Surgeons (ASPS) has issued a national alert urging patients to “do their homework” before undergoing procedures like “mommy makeovers” or Brazilian butt lifts. For the practicing physician, this consumer warning underscores the critical need for patients to verify board certification and facility accreditation. The investigation also called for greater transparency in physician disciplinary actions, as current board reviews can remain secret for years. Many of these surgery chains utilize aggressive social media marketing to promise minimal discomfort and 24-hour recovery times, which experts label as misleading. Unlike prescription drug ads, cosmetic surgery marketing remains largely unregulated, creating a significant safety risk for uninformed consumers. Families of victims allege that these companies prioritize customer acquisition and profit over basic surgical safety protocols. The ASPS emphasizes that plastic surgery is real surgery with real risks, and the risk of complications is never zero. Clinicians should counsel patients interested in body contouring to look past spa-like atmospheres and holiday discounts to research a surgeon’s history. We do not yet know if this investigation will lead to new federal regulations on cosmetic advertising or private equity involvement in clinical care. This story serves as a stark reminder of the vulnerability of patients in the commercial body-contouring market.
Image: PD
©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.




![2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]](https://www.2minutemedicine.com/wp-content/uploads/2025/05/ChatGPT-Image-May-12-2025-at-10_22_23-AM-75x75.png)


